The Notice That Never Gets Sent Pharmaceutical companies do not issue press releases announcing lifecycle extension campaigns. They do not […]

Executive Summary Most biopharma packaging sales reps knock on the wrong doors at the wrong time. They call on brand-side

On April 16, 2026, OpenAI did something it had never done before: it shipped a model designed not to chat,

When Humira lost its final U.S. patent protection in January 2023, more than thirty companies had already committed manufacturing capacity

The Answer Is Not 20 Years Every pharmaceutical patent lawyer knows the frustration. A client asks how long drug patent

The pharmaceutical industry has been stuck in a productivity rut for decades. We spend billions of dollars and ten years

The 36-Month Window Most Vendors Miss Every year, billions of dollars in brand pharmaceutical revenue disappear within months of patent

The pharmaceutical industry’s most elegant competitive weapon is also its most misunderstood. When a brand-name drug manufacturer launches its own

The Date That Actually Controls Generic Entry Walk into almost any pharmaceutical business development meeting, and the discussion of competitive